Page 19 - Read Online
P. 19

Li et al. Microbiome Res Rep 2024;3:26  https://dx.doi.org/10.20517/mrr.2023.57  Page 13 of 16


                RapidAIM protocol; (B) PC1  vs. PC2; (C) PC2  vs. PC3; (D) Hierarchical clustering of samples showing 72-hour samples of GutAlive
                differentiated from 72-hour samples of our in-house buffer; (E) Comparison of the responses of 72-hour samples to kestose between the
                (in-house) Buffer group and GutAlive group, Euler plot (area proportional Venn plot) showing numbers of significantly increased COGs
                by t-test (P values-adjusted by FDR); (F) Pathways corresponding to significantly increased COGs in response to kestose. COGs only in
                the GutAlive group (blue lines), only in the Buffer group (red lines), and shared responses (black lines) are shown.


               were processed on the day of collection, the 72-hour sample showed a separation of the metaproteomics
               profiles from the other groups, indicating a possible change in microbiome functionality that is specific to
               kestose uptake during the storage [Figure 3B-D]. PERMANOVA analysis showed that the storage period
               has a more significant impact in the GutAlive than in the in-house buffer group [Supplementary Tables 5
               and 6]. Therefore, we performed differential protein abundance analyses between kestose- and blank
               control- group samples of each preservation buffer, and we annotated proteins with COG and examined
               pathway responses. We observed that the different preservation methods could influence different numbers
               of COGs that exhibited a significant increase in the presence of kestose [Figure 3E], and the in-house buffer
               is sensitive in observing more responded COGs. Next, we mapped the responded COGs to microbial
               metabolism pathway maps in iPATH and found that in-house buffer storage method can better capture
               microbial metabolic pathway responses [Figure 3F]. The result suggests that storage of samples in our in-
               house buffer at 4 °C for 72 h prior to culturing/biobanking does not affect functional responses.


               DISCUSSION
               There have been various in vitro models to evaluate microbiome responses. Early in vitro gut microbiome
               models were based on large-scale bioreactors that are low-throughput and, due to the large volume of
               cultures, very costly owing to the considerable amount of compounds added. More recent advances in
               modeling the gut ecosystem include realizing the culturing of complex human gut microbiome in anaerobic
               intestine-on-a-chip models, enabling the observation of host-microbiome interactions . However, for the
                                                                                         [10]
               purpose of high-throughput compound screening, these models are not easily adaptable. This study
               describes the most recently optimized 2.0 version of RapidAIM, which consists of extensive details on stool
               sample collection, biobanking, in vitro culturing and stimulation, microbiome sample processing,
               metaproteomics measurement and data analysis. Using RapidAIM 2.0, we show consistent responses of
               individual microbiomes to prebiotic kestose across five different biobanking workflows; we also show that
               kestose had consistent functional effects across individuals and can be used as a positive control in the assay.

               In addition to the recommendations described in the protocol in the Method section, we recommend the
               following considerations for experimental design:

               (1) Plate layout. The experimental design will be performed based on a 96-well format. Taking into
                                              TM
               consideration the use of TMT11plex , we recommend that an 8 rows × 10 columns plate layout is used for
               each 96-well plate. The first column will later be used for the TMT reference sample, which will be
               generated after the desalting step. The last column will be left blank throughout the experiment.


               (2) Randomization. Compound treatments across all assay plates should be randomized. We provide the
                                                             [39]
               “96-well plate randomizer” tool in our iMetaLab Suite  to assist researchers with the study randomization
               (https://shiny.imetalab.ca/96_well_randomizer/). Randomizing within and across sample plates will be
               helpful to detect batch effects between plates, if any, and meet the criteria to apply batch removal tools .
                                                                                                       [40]
               Samples should be randomized again prior to LC-MS/MS analysis.
   14   15   16   17   18   19   20   21   22   23   24